The Investment Column: Oxford Instr
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.OXFORD INSTRUMENTS has been a victim both of its own optimism and its own success. It damaged its superconductor business, which was growing at 25 per cent a year, by moving to a new factory which turned out substandard product.
That's no crime when the product is complex magnetic resonance imaging equipment - scanners, in layman's terms - but the market blames the company for failing to adequately prepare it for bad news. Yesterday's results revealed the extent of the problem; superconductor profits fell from pounds 5.3m to pounds 110,000 and there is a huge backlog of orders.
Elsewhere, profits from superconductor instruments halved to pounds 3.6m as IBM, Intel and Toshiba cut back heavily on microchip investment amid overcapacity in chip markets.
Oxford Instruments' medical business, which makes instruments used to detect repetitive strain injury, suffered from the strength of sterling. Fortunately, the group's 49 per cent stake in brain scanner business OMT, which enjoyed record orders, delivered pounds 7.1m of profits.
Analysts expect pre-tax profits of about pounds 14m and 20p per share this year. While owners of the stock, which closed at 205p yesterday, should not exit now, potential investors should wait a while for Oxford Instruments to clear its backlog and pay a little extra for a more assured earnings outlook.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments